Indolent Systemic Mastocytosis – a Case Report

1. Mehta S, Masatkar V, Khare AK, Mittal A, Gupta LK. Blaschkoid mastocytosis. Indian J Dermatol Venereol Leprol. 2015;81(1):72-3.10.4103/0378-6323.14858425566909Search in Google Scholar

2. Metcalfe DD. Mast cell and mastocytosis. Blood.2008;112(4):946-56.10.1182/blood-2007-11-078097251513118684881Search in Google Scholar

3. Horny HP. Mastocytosis. In: Swerdlow S, Campo E,Harris NL, Jaffe ES, Pileri SA, Stein H, et al, editors. WHO classification of tumours of haematopoieticand lymphoid tissues. Lyon: International Agensy for Research and Cancer (IARC); 2008. p. 54-63.Search in Google Scholar

4. Janjua SA. Mastocytosis: from Nettleship and Darier to Metcalfe and Valent. Journal of Pakistan Association of Dermatologist. 2004;14:1-4.Search in Google Scholar

5. Demis DJ. The mastocytosis sydrome: clinical andbiological studies. Ann Intern Med. 1963;59(2):194-206.10.7326/0003-4819-59-2-19414049348Search in Google Scholar

6. Saikam S, Narahari A, Anisha M, Hanumanthayya K, Priya JT. A case report of indolent systemic mastocytosis. Journal of Evidence Based Medicine and Healthcare. 2016;3(36):1798-800.10.18410/jebmh/2016/402Search in Google Scholar

7. Marton I, Posfai E, Borbenyi Z, Bodor C, Papp G,Demeter J, et al. Therapeutic challenge during thelong-term follow-up of a patient with indolent systemic mastocytosis with extensive cutaneous involvement. Eur Rev Med Pharmacol Sci. 2015;19(9):1607-9.Search in Google Scholar

8. Somani VK, Sharma VK, Sita VN, Razvi F, Sucharita V. Congenital multiple cutaneous mastocytoma. Indian J Dermatol Venereol Leprol. 1996;62(3):175-7.Search in Google Scholar

9. Nayak S, Acharjya B, Devi B, Behera SK. Bullousmastocytosis. Indian J Dermatol. 2007;52(4):201-3.10.4103/0019-5154.37728Search in Google Scholar

10. Fritsche-Polanz R, Jordan JH, Feix A, Sperr WR,Sunder-Plassmann G, Valent P, et al. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and case of systemicmastocytosis. Br J Haematol. 2001;113(2):357-64.10.1046/j.1365-2141.2001.02783.x11380399Search in Google Scholar

11. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L,Metcalfe DD. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood. 2004;103(8):3222-5.10.1182/blood-2003-11-381615070706Search in Google Scholar

12. Hoffmann KM, Moser A, Lohse P, Winkler A, Binder B, Sovinz P, et al. Successful treatment of progressive cutaneous mastocytosis with imatinib in a2-year-old boy carrying a somatic KIT mutation. Blood 2008;112(5):1655-7.10.1182/blood-2008-03-14778518567837Search in Google Scholar

13. Ustun C, DeRemer DL, Akin C. Tyrosine kinase inhibitors in the treatment of systemic mastocytosis. Leuk Res. 2011;35(9):1143-52.10.1016/j.leukres.2011.05.00621641642Search in Google Scholar